Xiaolan Qian, Liqing Zhao, Qiying Wang, Dingguo Liu, Gaigai Ma
{"title":"Ultrasound guided stellate ganglion block for the treatment of tinnitus.","authors":"Xiaolan Qian, Liqing Zhao, Qiying Wang, Dingguo Liu, Gaigai Ma","doi":"10.1177/09287329251324068","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundTinnitus, a common auditory disorder, significantly impacts patient quality of life and lacks universally effective treatments. The integration of advanced imaging technology like ultrasound in therapeutic interventions offers new possibilities in healthcare.ObjectiveThis study evaluated the efficacy of ultrasound-guided stellate ganglion block as an innovative approach to managing tinnitus.MethodsEighty patients with tinnitus were randomly assigned to either a control group receiving standard drug therapy or an observation group treated with ultrasound-guided stellate ganglion block in addition to standard therapy. Key metrics, including clinical effectiveness rates, anxiety scores, and tinnitus disability index scores, were assessed pre- and post-treatment.ResultsPost-treatment outcomes revealed that the observation group exhibited significantly improved anxiety scores (38.74 ± 4.05 vs. 50.45 ± 4.86; P < 0.05) and tinnitus disability index scores (37.8 ± 17.56 vs. 50.4 ± 21.26; P < 0.05) compared to the control group. Additionally, the observation group achieved a 100% clinical efficacy rate, outperforming the control group's 84% (P < 0.05).ConclusionUltrasound-guided stellate ganglion block demonstrates superior efficacy in managing tinnitus compared to conventional drug therapy. This study underscores the potential of integrating advanced ultrasound technology into healthcare to optimize treatment outcomes for auditory disorders.</p>","PeriodicalId":48978,"journal":{"name":"Technology and Health Care","volume":" ","pages":"2083-2089"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technology and Health Care","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/09287329251324068","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundTinnitus, a common auditory disorder, significantly impacts patient quality of life and lacks universally effective treatments. The integration of advanced imaging technology like ultrasound in therapeutic interventions offers new possibilities in healthcare.ObjectiveThis study evaluated the efficacy of ultrasound-guided stellate ganglion block as an innovative approach to managing tinnitus.MethodsEighty patients with tinnitus were randomly assigned to either a control group receiving standard drug therapy or an observation group treated with ultrasound-guided stellate ganglion block in addition to standard therapy. Key metrics, including clinical effectiveness rates, anxiety scores, and tinnitus disability index scores, were assessed pre- and post-treatment.ResultsPost-treatment outcomes revealed that the observation group exhibited significantly improved anxiety scores (38.74 ± 4.05 vs. 50.45 ± 4.86; P < 0.05) and tinnitus disability index scores (37.8 ± 17.56 vs. 50.4 ± 21.26; P < 0.05) compared to the control group. Additionally, the observation group achieved a 100% clinical efficacy rate, outperforming the control group's 84% (P < 0.05).ConclusionUltrasound-guided stellate ganglion block demonstrates superior efficacy in managing tinnitus compared to conventional drug therapy. This study underscores the potential of integrating advanced ultrasound technology into healthcare to optimize treatment outcomes for auditory disorders.
期刊介绍：
Technology and Health Care is intended to serve as a forum for the presentation of original articles and technical notes, observing rigorous scientific standards. Furthermore, upon invitation, reviews, tutorials, discussion papers and minisymposia are featured. The main focus of THC is related to the overlapping areas of engineering and medicine. The following types of contributions are considered:
1.Original articles: New concepts, procedures and devices associated with the use of technology in medical research and clinical practice are presented to a readership with a widespread background in engineering and/or medicine. In particular, the clinical benefit deriving from the application of engineering methods and devices in clinical medicine should be demonstrated. Typically, full length original contributions have a length of 4000 words, thereby taking duly into account figures and tables.
2.Technical Notes and Short Communications: Technical Notes relate to novel technical developments with relevance for clinical medicine. In Short Communications, clinical applications are shortly described. 3.Both Technical Notes and Short Communications typically have a length of 1500 words.
Reviews and Tutorials (upon invitation only): Tutorial and educational articles for persons with a primarily medical background on principles of engineering with particular significance for biomedical applications and vice versa are presented. The Editorial Board is responsible for the selection of topics.
4.Minisymposia (upon invitation only): Under the leadership of a Special Editor, controversial or important issues relating to health care are highlighted and discussed by various authors.
5.Letters to the Editors: Discussions or short statements (not indexed).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
